Buy These 2 Likely Biotech Takeover Targets
November 23, 2015 at 17:30 PM EST
EGRX, BDSI: their cutting-edge drug portfolios and profitable relationships with industry heavyweights make these two rapidly advancing biotech companies prime takeover targets.